RIDUZIONE DEL SANGUINAMENTO NEGLI INTERVENTI IN CIRCOLAZIONE EXTRACORPOREA MEDIANTE L'USO DI ALTE DOSI DI APROTININA

Translated title of the contribution: Bleeding reduction in cardiopulmonary bypass procedures with high dose aprotinin

T. Gherli, A. Porcu, G. Padua, G. M. Marongiu, C. Antona, F. Alamanni, P. P. Bacciu

Research output: Contribution to journalArticle

Abstract

The great risk of severe infectious diseases transmission through blood transfusion, has increased during the last years the effort to reduce the bank blood and its derivative use. Many techniques have proposed to achieve this purpose during and post cardiopulmonary bypass: normovolemic hemodilution, perioperative blood autotransfusion, postoperative return of extra corporeal circuit and chest drains blood and the particular use of some drugs. In the last few years several reports have been presented in the literature concerning the reduction of intra and postoperative bleeding in cardiac surgery by high dose Aprotinin administration. A randomized study with the use of this pharmacologic agent is presented: a group of patients was treated with Aprotinin (shared in two subgroups receiving respectively a different dose of the drug) and a control group. The results were highly encouraging both because of the reduction of peri and postoperative bleeding and because of the bank blood use important reduction.

Original languageItalian
Pages (from-to)121-126
Number of pages6
JournalMinerva Cardioangiologica
Volume40
Issue number4
Publication statusPublished - 1992

Fingerprint

Blood Banks
Aprotinin
Cardiopulmonary Bypass
Hemorrhage
Autologous Blood Transfusions
Hemodilution
Infectious Disease Transmission
Drug and Narcotic Control
Blood Transfusion
Thoracic Surgery
Thorax
Control Groups
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Gherli, T., Porcu, A., Padua, G., Marongiu, G. M., Antona, C., Alamanni, F., & Bacciu, P. P. (1992). RIDUZIONE DEL SANGUINAMENTO NEGLI INTERVENTI IN CIRCOLAZIONE EXTRACORPOREA MEDIANTE L'USO DI ALTE DOSI DI APROTININA. Minerva Cardioangiologica, 40(4), 121-126.

RIDUZIONE DEL SANGUINAMENTO NEGLI INTERVENTI IN CIRCOLAZIONE EXTRACORPOREA MEDIANTE L'USO DI ALTE DOSI DI APROTININA. / Gherli, T.; Porcu, A.; Padua, G.; Marongiu, G. M.; Antona, C.; Alamanni, F.; Bacciu, P. P.

In: Minerva Cardioangiologica, Vol. 40, No. 4, 1992, p. 121-126.

Research output: Contribution to journalArticle

Gherli, T, Porcu, A, Padua, G, Marongiu, GM, Antona, C, Alamanni, F & Bacciu, PP 1992, 'RIDUZIONE DEL SANGUINAMENTO NEGLI INTERVENTI IN CIRCOLAZIONE EXTRACORPOREA MEDIANTE L'USO DI ALTE DOSI DI APROTININA', Minerva Cardioangiologica, vol. 40, no. 4, pp. 121-126.
Gherli, T. ; Porcu, A. ; Padua, G. ; Marongiu, G. M. ; Antona, C. ; Alamanni, F. ; Bacciu, P. P. / RIDUZIONE DEL SANGUINAMENTO NEGLI INTERVENTI IN CIRCOLAZIONE EXTRACORPOREA MEDIANTE L'USO DI ALTE DOSI DI APROTININA. In: Minerva Cardioangiologica. 1992 ; Vol. 40, No. 4. pp. 121-126.
@article{3fe999ef4ed64206bcaec4977fc6709e,
title = "RIDUZIONE DEL SANGUINAMENTO NEGLI INTERVENTI IN CIRCOLAZIONE EXTRACORPOREA MEDIANTE L'USO DI ALTE DOSI DI APROTININA",
abstract = "The great risk of severe infectious diseases transmission through blood transfusion, has increased during the last years the effort to reduce the bank blood and its derivative use. Many techniques have proposed to achieve this purpose during and post cardiopulmonary bypass: normovolemic hemodilution, perioperative blood autotransfusion, postoperative return of extra corporeal circuit and chest drains blood and the particular use of some drugs. In the last few years several reports have been presented in the literature concerning the reduction of intra and postoperative bleeding in cardiac surgery by high dose Aprotinin administration. A randomized study with the use of this pharmacologic agent is presented: a group of patients was treated with Aprotinin (shared in two subgroups receiving respectively a different dose of the drug) and a control group. The results were highly encouraging both because of the reduction of peri and postoperative bleeding and because of the bank blood use important reduction.",
author = "T. Gherli and A. Porcu and G. Padua and Marongiu, {G. M.} and C. Antona and F. Alamanni and Bacciu, {P. P.}",
year = "1992",
language = "Italian",
volume = "40",
pages = "121--126",
journal = "Minerva Cardioangiologica",
issn = "0026-4725",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

TY - JOUR

T1 - RIDUZIONE DEL SANGUINAMENTO NEGLI INTERVENTI IN CIRCOLAZIONE EXTRACORPOREA MEDIANTE L'USO DI ALTE DOSI DI APROTININA

AU - Gherli, T.

AU - Porcu, A.

AU - Padua, G.

AU - Marongiu, G. M.

AU - Antona, C.

AU - Alamanni, F.

AU - Bacciu, P. P.

PY - 1992

Y1 - 1992

N2 - The great risk of severe infectious diseases transmission through blood transfusion, has increased during the last years the effort to reduce the bank blood and its derivative use. Many techniques have proposed to achieve this purpose during and post cardiopulmonary bypass: normovolemic hemodilution, perioperative blood autotransfusion, postoperative return of extra corporeal circuit and chest drains blood and the particular use of some drugs. In the last few years several reports have been presented in the literature concerning the reduction of intra and postoperative bleeding in cardiac surgery by high dose Aprotinin administration. A randomized study with the use of this pharmacologic agent is presented: a group of patients was treated with Aprotinin (shared in two subgroups receiving respectively a different dose of the drug) and a control group. The results were highly encouraging both because of the reduction of peri and postoperative bleeding and because of the bank blood use important reduction.

AB - The great risk of severe infectious diseases transmission through blood transfusion, has increased during the last years the effort to reduce the bank blood and its derivative use. Many techniques have proposed to achieve this purpose during and post cardiopulmonary bypass: normovolemic hemodilution, perioperative blood autotransfusion, postoperative return of extra corporeal circuit and chest drains blood and the particular use of some drugs. In the last few years several reports have been presented in the literature concerning the reduction of intra and postoperative bleeding in cardiac surgery by high dose Aprotinin administration. A randomized study with the use of this pharmacologic agent is presented: a group of patients was treated with Aprotinin (shared in two subgroups receiving respectively a different dose of the drug) and a control group. The results were highly encouraging both because of the reduction of peri and postoperative bleeding and because of the bank blood use important reduction.

UR - http://www.scopus.com/inward/record.url?scp=0026664846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026664846&partnerID=8YFLogxK

M3 - Articolo

C2 - 1382251

AN - SCOPUS:0026664846

VL - 40

SP - 121

EP - 126

JO - Minerva Cardioangiologica

JF - Minerva Cardioangiologica

SN - 0026-4725

IS - 4

ER -